Patient-Level Model Predicts In-Hospital Mortality in Acute MI

Share this content:
Patient-Level Model Predicts In-Hospital Mortality in Acute MI
Patient-Level Model Predicts In-Hospital Mortality in Acute MI

THURSDAY, Aug. 4, 2016 (HealthDay News) -- A parsimonious patient-level clinical risk model can predict in-hospital mortality for patients with acute myocardial infarction, according to a study published in the Aug. 9 issue of the Journal of the American College of Cardiology.

Robert L. McNamara, M.D., from the Yale University School of Medicine in New Haven, Conn., and colleagues developed and validated a parsimonious patient-level clinical risk model of in-hospital mortality for patients with acute myocardial infarction. The population of 243,440 patients from 655 hospitals was divided into a 60 percent sample for derivation of the model and a 40 percent sample for validation of the model.

The researchers found that in-hospital mortality was 4.6 percent. Independent associations for in-hospital mortality were seen for age, heart rate, systolic blood pressure, presentation after cardiac arrest, presentation in cardiogenic shock, presentation in heart failure, presentation with ST-segment elevation myocardial infarction (STEMI), creatinine clearance, and troponin ratio. The C-statistic for the model was 0.88, with good calibration. In subgroups based on age, sex, race, transfer status, and presence of diabetes mellitus, renal dysfunction, cardiac arrest, cardiogenic shock, and STEMI, the model performed well. Across risk groups, the observed mortality rates varied substantially, ranging from 0.4 to 49.5 percent in the lowest and highest risk groups.

"This parsimonious risk model for in-hospital mortality is a valid instrument for risk adjustment and risk stratification in contemporary patients with acute myocardial infarction," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for ~25% ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »